Today

Agents

Chat

Arena

Discover

More

App

Inmune Bio Targets UK Maa In Q4 2026, EU Maa And US BLA In Q1 2027 - INMB News | Rallies

Inmune Bio Targets UK Maa In Q4 2026, EU Maa And US BLA In Q1 2027

INMB•2026-08-26

Regulatory filing targets

INmune Bio Inc said the company targets UK MAA in Q4 2026, EU MAA and U.S. BLA in Q1 2027.
INmune Bio advances ebstrocel™ toward European marketing authorization with EMA regulatory filings.

Related News

Biohaven jumps on SK Biopharma epilepsy licensing deal worth up to $795 million

BHVN•2026-08-26

Ameresco director Brian C. Cox acquires 4,625 shares for $100,055.50

AMRC•2026-08-26

Piper Sandler upgrades Neogen, shares gain

2026-08-26

Abercrombie raises full-year sales forecast on resilient apparel demand

ANF•2026-08-26

Canada's Reklaim Q2 revenue more than doubles

XLK•2026-08-26